Cabot Corp CBT
We take great care to ensure that the data presented and summarized in this overview for CABOT CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CBT
View all-
Black Rock Inc. New York, NY7.22MShares$639 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.26MShares$554 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.49MShares$397 Million0.09% of portfolio
-
Earnest Partners LLC Atlanta, GA3.27MShares$290 Million1.66% of portfolio
-
State Street Corp Boston, MA2.1MShares$185 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC1.67MShares$148 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.34MShares$118 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA1.28MShares$114 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA1.23MShares$109 Million3.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.22MShares$108 Million0.08% of portfolio
Latest Institutional Activity in CBT
Top Purchases
Top Sells
About CBT
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Insider Transactions at CBT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 18
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,197
-5.89%
|
$453,276
$108.82 P/Share
|
Nov 18
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,090
+12.4%
|
-
|
Nov 18
2024
|
Sean D Keohane President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,631
-5.4%
|
$2,228,148
$108.82 P/Share
|
Nov 18
2024
|
Sean D Keohane President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,842
+10.71%
|
-
|
Nov 18
2024
|
Karen A Kalita SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,657
-6.47%
|
$286,956
$108.82 P/Share
|
Nov 18
2024
|
Karen A Kalita SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,153
+13.03%
|
-
|
Nov 18
2024
|
Lisa M Dumont VP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-5.01%
|
$54,972
$108.82 P/Share
|
Nov 18
2024
|
Lisa M Dumont VP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,472
+12.65%
|
-
|
Nov 18
2024
|
Jeff Ji Zhu Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,024
-2.6%
|
$218,592
$108.82 P/Share
|
Nov 18
2024
|
Jeff Ji Zhu Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
8,465
+9.8%
|
-
|
Nov 18
2024
|
Hobart Kalkstein Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,765
-6.61%
|
$406,620
$108.82 P/Share
|
Nov 18
2024
|
Hobart Kalkstein Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
8,610
+13.14%
|
-
|
Nov 13
2024
|
Lisa M Dumont VP, Controller & CAO |
SELL
Bona fide gift
|
Direct |
1,054
-10.82%
|
-
|
Nov 13
2024
|
Lisa M Dumont VP, Controller & CAO |
SELL
Open market or private sale
|
Direct |
865
-8.16%
|
$96,015
$111.74 P/Share
|
Nov 13
2024
|
Jeff Ji Zhu Executive Vice President |
SELL
Open market or private sale
|
Direct |
14,566
-17.34%
|
$1,645,958
$113.25 P/Share
|
Nov 12
2024
|
Lisa M Dumont VP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
454
-4.1%
|
$50,848
$112.54 P/Share
|
Nov 12
2024
|
Jeff Ji Zhu Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,143
-1.34%
|
$128,016
$112.54 P/Share
|
Nov 12
2024
|
Sean D Keohane President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,824
-3.4%
|
$1,324,288
$112.54 P/Share
|
Nov 12
2024
|
Karen A Kalita SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,618
-4.43%
|
$181,216
$112.54 P/Share
|
Nov 12
2024
|
Erica Mc Laughlin Executive Vice President, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,552
-4.0%
|
$285,824
$112.54 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 134K shares |
---|---|
Exercise of conversion of derivative security | 216K shares |
Payment of exercise price or tax liability | 53.7K shares |
---|---|
Bona fide gift | 1.05K shares |
Open market or private sale | 268K shares |